1365238-04-5

Basic information

• Product Name: 4-{6-chloro-8-[(2-sulfamoylethyl)amino]imidazo[1,2-b]pyridazin-3-yl}-N-cyclopropylbenzamide
• Synonyms: 4-{6-chloro-8-[(2-sulfamoylethyl)amino]imidazo[1,2-b]pyridazin-3-yl}-N-cyclopropylbenzamide
• CAS NO: 1365238-04-5
• Molecular Weight: 434.906
• Mol File: 1365238-04-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-{6-chloro-8-[(2-sulfamoylethyl)amino]imidazo[1,2-b]pyridazin-3-yl}-N-cyclopropylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{6-chloro-8-[(2-sulfamoylethyl)amino]imidazo[1,2-b]pyridazin-3-yl}-N-cyclopropylbenzamide(1365238-04-5)
• EPA Substance Registry System: 4-{6-chloro-8-[(2-sulfamoylethyl)amino]imidazo[1,2-b]pyridazin-3-yl}-N-cyclopropylbenzamide(1365238-04-5)

Safety Data

• Hazardous Substances Data: 1365238-04-5(Hazardous Substances Data)

Upstream product

• 933190-51-3 8-bromo-6-chloro-imidazo[1,2-b]pyridazine 
• 860173-33-7 4-(cyclopropylaminocarbonyl)phenylboronic acid pinacol ester 
• 1263425-59-7 8-bromo-6-chloro-3-iodoimidazo[1,2-b]pyridazine 
• 89756-60-5 taurinamide hydrochloride 

Relevant articles and documents

SUBSTITUTED IMIDAZOPYRIDAZINES

The present invention relates to substituted imidazopyridazine compounds of general formula (l), which are Mps -1 (Monopolar Spindle 1) Kinase inhibitors (also known as Tyrosine Threonine Kinase, TTK) in which R3, R5, and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.